Definition of reinfarction in the HERO-2 trialw23
| Clinical scenario | Criteria |
|---|---|
| CABG, coronary artery bypass grafting; CK, creatine kinase; PCI, percutaneous coronary intervention; ULRR, upper limit of the reference range. | |
| Recurrent symptoms occurring within 18 hours | Chest pain lasting ⩾30 minutes |
| and ⩾2 mm of ST elevation | |
| Recurrent symptoms occurring after lasting >18 hours | CK rise to >2 × ULRR and >50% above previous baseline value |
| or CK-MB value >ULRR and >50% above previous baseline value | |
| or new left bundle branch block or new Q waves | |
| Following PCI | CK rise to >3 × ULRR |
| or CK-MB value >3 × ULRR | |
| or new left bundle branch block or new Q waves | |
| Following CABG | CK rise to >5 × ULRR |
| or CK-MB value >5 × ULRR | |
| or new left bundle branch block or new Q waves | |